Cargando…

Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2

OBJECTIVES: A major COVID‐19 vaccine strategy is to induce antibodies that prevent interaction between the Spike protein's receptor‐binding domain (RBD) and angiotensin‐converting enzyme 2 (ACE2). These vaccines will also induce T‐cell responses. However, concerns were raised that aberrant vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Manisha, Ozberk, Victoria, Eskandari, Sharareh, Shalash, Ahmed O, Joyce, Michael A, Saffran, Holly A, Day, Christopher J, Lepletier, Ailin, Spillings, Belinda L, Mills, Jamie‐Lee, Calcutt, Ainslie, Fan, Fan, Williams, James T, Stanisic, Danielle I, Hattingh, Laetitia, Gerrard, John, Skwarczynski, Mariusz, Mak, Johnson, Jennings, Michael P, Toth, Istvan, Tyrrell, D Lorne, Good, Michael F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937407/ https://www.ncbi.nlm.nih.gov/pubmed/33732459 http://dx.doi.org/10.1002/cti2.1260

Ejemplares similares

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
por: Ozberk, Victoria, et al.
Publicado: (2021)

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy
por: Pandey, Manisha, et al.
Publicado: (2018)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma
por: Pandey, Manisha, et al.
Publicado: (2016)

Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice
por: Pandey, Manisha, et al.
Publicado: (2019)

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models
por: Langshaw, Emma L., et al.
Publicado: (2023)

Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens
por: Islam, Md. Tanjir, et al.
Publicado: (2022)

Protocol to quantify glycan-mediated binding between viral particles and human peripheral blood mononuclear cells using nanoluciferase
por: Spillings, Belinda L., et al.
Publicado: (2023)

Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model
por: Reynolds, Simone, et al.
Publicado: (2023)

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines
por: Ssemaganda, Aloysious, et al.
Publicado: (2019)

Thymus-derived hormonal and cellular control of cancer
por: Savino, Wilson, et al.
Publicado: (2023)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites
por: Low, Leanne M., et al.
Publicado: (2018)

Contribution of cryptic epitopes in designing a group A streptococcal vaccine
por: Ozberk, Victoria, et al.
Publicado: (2018)

Complement Receptor 3 Mediates HIV-1 Transcytosis across an Intact Cervical Epithelial Cell Barrier: New Insight into HIV Transmission in Women
por: Day, Christopher J., et al.
Publicado: (2022)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Neutralising Antibodies against Ricin Toxin
por: Prigent, Julie, et al.
Publicado: (2011)

Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression
por: Phillips, Zachary N., et al.
Publicado: (2022)

Protocol to visualize glycan-mediated binding between virus and human blood mononuclear cells using thin-section transmission electron microscopy
por: Spillings, Belinda L., et al.
Publicado: (2023)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Malaria Vaccines: Progress to Date
por: Stanisic, Danielle I., et al.
Publicado: (2023)

Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein
por: Jaberolansar, Noushin, et al.
Publicado: (2017)

Calcium Contributes to Polarized Targeting of HIV Assembly Machinery by Regulating Complex Stability
por: Kishor, Chandan, et al.
Publicado: (2022)

Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria
por: Stanisic, Danielle I., et al.
Publicado: (2021)

A high-resolution mass spectrometry based proteomic dataset of human regulatory T cells
por: Weerakoon, Harshi, et al.
Publicado: (2021)

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
por: Lu, Lantian, et al.
Publicado: (2021)

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004)

Neutralisation pockets and spectral lines
por: Gröbner, Oswald
Publicado: (1972)

On Toxic Neutralisations: II. Reconstitution
por: Richardson, Benjamin Ward
Publicado: (1894)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection
por: Duncan, Joseph K. Sampson, et al.
Publicado: (2023)

Electron cooling with neutralised electron beams
por: Bosser, Jacques, et al.
Publicado: (1994)

Electron cooling with neutralised electron beams
por: Bosser, J, et al.
Publicado: (1994)

On Toxic Neutralisations: I.—Isomeric Variation
por: Richardson, Benjamin Ward
Publicado: (1894)

Cannot write session to /tmp/vufind_sessions/sess_h0khnsk6q0moe8js4ige2orb8s